{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:44:43Z","timestamp":1792579483210,"version":"4.5.0"},"reference-count":68,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch Arthritis Society, ZonMW","award":["10390012110002"],"award-info":[{"award-number":["10390012110002"]}]},{"name":"Bristol Myers Squibb","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["714312"],"award-info":[{"award-number":["714312"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,8,12]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/bmjopen-2026-118495","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:25:20Z","timestamp":1792578320000},"page":"e118495","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging-guided treatment strategy compared to standard care in at-risk individuals for rheumatoid arthritis: a cost-utility analysis"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6592-1850","authenticated-orcid":false,"given":"Sterre","family":"Bour","sequence":"first","affiliation":[{"name":"Erasmus School of Health Policy & Management, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Van Mulligen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Rheumatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Goossens","sequence":"additional","affiliation":[{"name":"Erasmus School of Health Policy & Management, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-6222","authenticated-orcid":false,"given":"Pascal Hendrik Pieter","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8572-1437","authenticated-orcid":false,"given":"Annette","family":"van der Helm - van Mil","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Rheumatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8706-3159","authenticated-orcid":false,"given":"Maureen","family":"Rutten-van Molken","sequence":"additional","affiliation":[{"name":"Erasmus School of Health Policy & Management, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands"},{"name":"Institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"2026102103251820000_16.10.e118495.1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01661"},{"key":"2026102103251820000_16.10.e118495.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200367"},{"key":"2026102103251820000_16.10.e118495.3","unstructured":"Royal Dutch Society for Physical Therapy . KNGF guideline rheumatoid arthritis. 2018."},{"key":"2026102103251820000_16.10.e118495.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"2026102103251820000_16.10.e118495.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh199"},{"key":"2026102103251820000_16.10.e118495.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202911"},{"key":"2026102103251820000_16.10.e118495.7","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s10198-007-0088-8","article-title":"The burden of rheumatoid arthritis and access to treatment: health burden and costs","volume":"8 Suppl 2","author":"Lundkvist","year":"2008","journal-title":"Eur J Health Econ"},{"key":"2026102103251820000_16.10.e118495.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210602"},{"key":"2026102103251820000_16.10.e118495.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102797"},{"key":"2026102103251820000_16.10.e118495.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209846"},{"key":"2026102103251820000_16.10.e118495.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-2102-9","article-title":"Improvement of symptoms in clinically suspect arthralgia and resolution of subclinical joint inflammation: a longitudinal study in patients that did not progress to clinical arthritis","volume":"22","author":"Ten Brinck","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2026102103251820000_16.10.e118495.12","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/rheumatology\/kex340","article-title":"The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia","volume":"56","author":"ten Brinck","year":"2017","journal-title":"Rheumatology"},{"key":"2026102103251820000_16.10.e118495.13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/BOR.0000000000000282","article-title":"MRI and ultrasound in rheumatoid arthritis","volume":"28","author":"Mathew","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2026102103251820000_16.10.e118495.14","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02685-7","article-title":"Ultrasound in clinically suspect arthralgia: the role of power Doppler to predict rheumatoid arthritis development","volume":"23","author":"Molina Collada","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2026102103251820000_16.10.e118495.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208235"},{"key":"2026102103251820000_16.10.e118495.16","doi-asserted-by":"crossref","DOI":"10.1186\/ar3028","article-title":"The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study","volume":"12","author":"van de Stadt","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2026102103251820000_16.10.e118495.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1715-8","article-title":"What is the value of musculoskeletal ultrasound in patients presenting with arthralgia to predict inflammatory arthritis development? A systematic literature review","volume":"20","author":"van den Berg","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2026102103251820000_16.10.e118495.18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/rheumatology\/kez436","article-title":"Improving the feasibility of MRI in clinically suspect arthralgia for prediction of rheumatoid arthritis by omitting scanning of the feet","volume":"59","author":"Boer","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2026102103251820000_16.10.e118495.19","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000870","article-title":"Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives","volume":"5","author":"Burgers","year":"2019","journal-title":"RMD Open"},{"key":"2026102103251820000_16.10.e118495.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103217"},{"key":"2026102103251820000_16.10.e118495.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01193-X"},{"key":"2026102103251820000_16.10.e118495.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02650-8"},{"key":"2026102103251820000_16.10.e118495.23","doi-asserted-by":"crossref","unstructured":"Mulligen E , Bour SS , Goossens LMA , et al . Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial. Ann Rheum Dis 2024. doi:10.1136\/ard-2024-226286","DOI":"10.1136\/ard-2024-226286"},{"key":"2026102103251820000_16.10.e118495.24","unstructured":"Federatie Medisch Specialisten . Reumato\u00efde artritis. 2023. Available: https:\/\/richtlijnendatabase.nl\/richtlijn\/reumato_de_artritis_ra\/startpagina_-_reumatoide_artritis.html [Accessed 25 Mar 2025]."},{"key":"2026102103251820000_16.10.e118495.25","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12454941"},{"key":"2026102103251820000_16.10.e118495.26","unstructured":"Zorginstituut Nederland . Guideline for economic evaluations in healthcare. 2024."},{"key":"2026102103251820000_16.10.e118495.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.10.008"},{"key":"2026102103251820000_16.10.e118495.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003296","article-title":"Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in the Netherlands","volume":"17","author":"Matthijssen","year":"2020","journal-title":"PLoS Med"},{"key":"2026102103251820000_16.10.e118495.29","unstructured":"Vam Schaardenburg D , Shackleton D , Van Tubergen A , et al . Richtlijn diagnostiek van reumatoide artritis. 2018."},{"key":"2026102103251820000_16.10.e118495.30","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-020-04731-2","article-title":"TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol","volume":"21","author":"Niemantsverdriet","year":"2020","journal-title":"Trials"},{"key":"2026102103251820000_16.10.e118495.31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/occmed\/kqi171","article-title":"Systematic review of studies of productivity loss due to rheumatoid arthritis","volume":"56","author":"Burton","year":"2006","journal-title":"Occup Med (Chic Ill)"},{"key":"2026102103251820000_16.10.e118495.32","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000204257.25875.04"},{"key":"2026102103251820000_16.10.e118495.33","unstructured":"iMTA Productivity and Health Research Group . Manual iMTA Medical Cost Questionnaire (iMCQ). 2018."},{"key":"2026102103251820000_16.10.e118495.34","unstructured":"Peeters S , Kanters T . Costing manual: methods and reference prices for economic evaluations in healthcare. 2024."},{"key":"2026102103251820000_16.10.e118495.35","doi-asserted-by":"crossref","DOI":"10.1186\/ar3141","article-title":"Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis","volume":"12","author":"Zhang","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2026102103251820000_16.10.e118495.36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch Tariff for the Five-Level Version of EQ-5D","volume":"19","author":"Versteegh","year":"2016","journal-title":"Value Health"},{"key":"2026102103251820000_16.10.e118495.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205522"},{"key":"2026102103251820000_16.10.e118495.38","unstructured":"van der Helm-van Mil A , Boxma-de Klerk BM , van Steenbergen H , et al . Early recognition and prevention of RA. Available: https:\/\/www.lumc.nl\/en\/about-lumc\/afdelingen\/reumatologie\/rheumatoid-arthritis-ra\/early-recognition-and-prevention-of-ra\/ [Accessed 25 Sep 2023]."},{"key":"2026102103251820000_16.10.e118495.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.04.008"},{"key":"2026102103251820000_16.10.e118495.40","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq230"},{"key":"2026102103251820000_16.10.e118495.41","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-025-05865-9","article-title":"The natural course of health-related quality of life in patients with clinically suspect arthralgia: a longitudinal study in progressors and non-progressors to rheumatoid arthritis","volume":"45","author":"Bour","year":"2025","journal-title":"Rheumatol Int"},{"key":"2026102103251820000_16.10.e118495.42","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/art.39749","article-title":"Magnetic Resonance Imaging\u2013Detected Features of Inflammation and Erosions in Symptom\u2010Free Persons From the General Population","volume":"68","author":"Mangnus","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026102103251820000_16.10.e118495.43","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/rheumatology\/kex235","article-title":"Using a reference when defining an abnormal MRI reduces false-positive MRI results-a longitudinal study in two cohorts at risk for rheumatoid arthritis","volume":"56","author":"Boer","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026102103251820000_16.10.e118495.44","doi-asserted-by":"publisher","DOI":"10.1002\/art.21493"},{"key":"2026102103251820000_16.10.e118495.45","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068361"},{"key":"2026102103251820000_16.10.e118495.46","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00256-022-04238-8","article-title":"Towards a simplified fluid-sensitive MRI protocol in small joints of the hand in early arthritis patients: reliability between modified Dixon and regular Gadolinium enhanced TSE fat saturated MRI-sequences","volume":"52","author":"Boeren","year":"2023","journal-title":"Skeletal Radiol"},{"key":"2026102103251820000_16.10.e118495.47","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1824-z"},{"key":"2026102103251820000_16.10.e118495.48","unstructured":"CBS . Levensverwachting; geslacht, leeftijd (per jaar en periode van vijf jaren) Gewijzigd op. 2024. Available: https:\/\/opendata.cbs.nl\/#\/CBS\/nl\/dataset\/37360ned\/table?ts=1731422880682 [Accessed 11 Dec 2024]."},{"key":"2026102103251820000_16.10.e118495.49","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00844-y"},{"key":"2026102103251820000_16.10.e118495.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.02.008"},{"key":"2026102103251820000_16.10.e118495.51","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"2026102103251820000_16.10.e118495.52","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1016\/S2665-9913(24)00196-6","article-title":"Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial","volume":"6","author":"Dumoulin","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2026102103251820000_16.10.e118495.53","unstructured":"Rech J , Ostergaard M , Tascilar K , et al . Abatacept reverses subclinical arthritis in patients with high-risk to develop rheumatoid arthritis-results from the randomized, placebo-controlled ARIAA Study in RA-at Risk Patients. Arthritis Rheumatol 2021;73."},{"key":"2026102103251820000_16.10.e118495.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02649-1"},{"key":"2026102103251820000_16.10.e118495.55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ard.2025.05.326","article-title":"OP0324 Long-term sustainability of methotrexate intervention in anticitrullinated protein antibody-positive and autoantibody-negative arthralgia patients at increased risk for rheumatoid arthritis on disease development and disease burden: 5-year results from the TREAT EARLIER trial","volume":"84","author":"Dumoulin","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026102103251820000_16.10.e118495.56","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.1697"},{"key":"2026102103251820000_16.10.e118495.57","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ard.2025.01.021","article-title":"EULAR\/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia","volume":"84","author":"van Steenbergen","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026102103251820000_16.10.e118495.58","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202289"},{"key":"2026102103251820000_16.10.e118495.59","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003031","article-title":"To treat or not to treat? Current attitudes on treatment aimed at modifying the disease burden in clinically suspect arthralgia: a survey among participants of the TREAT EARLIER trial and healthcare professionals","volume":"9","author":"Krijbolder","year":"2023","journal-title":"RMD Open"},{"key":"2026102103251820000_16.10.e118495.60","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/acr.23841","article-title":"I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis","volume":"72","author":"Mosor","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026102103251820000_16.10.e118495.61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/imj.15537","article-title":"Rheumatoid arthritis is a preventable disease: 11 ways to reduce your patients\u2019 risk","volume":"52","author":"Koller-Smith","year":"2022","journal-title":"Intern Med J"},{"key":"2026102103251820000_16.10.e118495.62","doi-asserted-by":"publisher","DOI":"10.3310\/hta22440"},{"key":"2026102103251820000_16.10.e118495.63","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.3390\/app13063693","article-title":"Recent Advances in Artificial Intelligence-Assisted Ultrasound Scanning","volume":"13","author":"Tenajas","year":"2023","journal-title":"Applied Sciences"},{"key":"2026102103251820000_16.10.e118495.64","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000428","article-title":"Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system","volume":"3","author":"D\u2019Agostino","year":"2017","journal-title":"RMD Open"},{"key":"2026102103251820000_16.10.e118495.65","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000427","article-title":"Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 2: reliability and application to multiple joints of a standardised consensus-based scoring system","volume":"3","author":"Terslev","year":"2017","journal-title":"RMD Open"},{"key":"2026102103251820000_16.10.e118495.66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2021-002128","article-title":"The value of MRI for detecting subclinical joint inflammation in clinically suspect arthralgia","volume":"8","author":"Boeren","year":"2022","journal-title":"RMD Open"},{"key":"2026102103251820000_16.10.e118495.67","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1915-x"},{"key":"2026102103251820000_16.10.e118495.68","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161433"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-118495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:25:25Z","timestamp":1792578325000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-118495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,21]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bmjopen-2026-118495"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-118495","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}